. Author manuscript; available in PMC: 2021 Apr 1.

Published in final edited form as: Neurotox Res. 2020 Jan 4;37(4):788–799. doi: 10.1007/s12640-019-00158-z

Table 3.

Relationships between clinical/demographic variables and changes in brain metrics from Time 1 to 3 for the breast cancer group

	Regression Coefficient
	Mean Cortical Thickness	Predicted Brain Age
Years Education	.07	−.11
Postmenopausal	−.22	.35
Cancer Stage at Diagnosis	−.37	.31
Anthracycline Chemotherapy	.08	−.09
Hormone Receptor Positive	−.33	.24
HER2 Receptor Positive	.02	−.06
Mastectomy	−.03	.38
Neoadjuvant Chemotherapy	−.15	−.45^*
Hormonal Blockade	−.10	.53^*
Radiation Treatment between T2-T3	−.20	.41^*

p < 0.05